Back to Search
Start Over
BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis.
- Source :
- Therapeutic Advances in Hematology; Jan-Dec2020, Vol. 11, p1-12, 12p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 20406207
- Volume :
- 11
- Database :
- Complementary Index
- Journal :
- Therapeutic Advances in Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 173503406
- Full Text :
- https://doi.org/10.1177/2040620720932686